scholarly article | Q13442814 |
P50 | author | Heidi E Drummer | Q38323304 |
P2093 | author name string | Irene Boo | |
Hans-Jürgen Netter | |||
Patricia T K Vietheer | |||
P433 | issue | 4 | |
P921 | main subject | Hepatitis B virus | Q6844 |
Hepatitis C virus | Q708693 | ||
immunization | Q1415366 | ||
P304 | page(s) | 477-487 | |
P577 | publication date | 2007-01-01 | |
P1433 | published in | Antiviral Therapy | Q4775353 |
P1476 | title | Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies | |
P478 | volume | 12 |
Q27488724 | Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats |
Q34389522 | HIV p24 as scaffold for presenting conformational HIV Env antigens |
Q92881172 | Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms |
Q37178225 | Immune responses during acute and chronic infection with hepatitis C virus |
Q28604286 | Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus |
Q35739112 | Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model. |
Q34933721 | Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus |
Q34322342 | Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever |
Q36281860 | Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity. |
Q47100523 | Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C. |
Q37505405 | Prospects for prophylactic hepatitis C vaccines based on virus-like particles |
Q33812653 | Subviral particle as vaccine and vaccine platform |
Q41711102 | The Process of Wrapping Virus Revealed by a Force Tracing Technique and Simulations |
Q45324462 | The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine |
Q45324534 | Virus like particles as a platform for cancer vaccine development. |
Q39261291 | Whole Pichia pastoris yeast expressing measles virus nucleoprotein as a production and delivery system to multimerize Plasmodium antigens |
Search more.